Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19

被引：0
|
作者：
Jianhua Liu
Dongsheng Tu
Janet Dancey
Leonard Reyno
Kathleen I. Pritchard
Joseph Pater
Lesley K Seymour
机构：
[1] Cancer Research Institute,National Cancer Institute of Canada Clinical Trials Group
[2] Queens University,undefined
来源：
Breast Cancer Research and Treatment | 2006年 / 100卷
关键词：
Quality of life; Analyses; Statistical methods; DPPE; Breast cancer; Tesmilifene;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：263 / 271
页数：8
相关论文
共 50 条
  • [31] Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer
    Smyth, Emily Nash
    Shen, Wei
    Bowman, Lee
    Peterson, Patrick
    John, William
    Melemed, Allen
    Liepa, Astra M.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2016, 14
  • [32] TREATMENT OF ADVANCED AND REFRACTORY BREAST-CANCER WITH DOXORUBICIN, VINCRISTINE AND CONTINUOUS INFUSION OF VERAPAMIL - A PHASE I-II CLINICAL-TRIAL
    RIES, F
    DICATO, M
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1991, 8 (01): : 39 - 43
  • [33] The Effect of Melatonin on Increasing the Health Related Quality of Life in Non-Metastatic Breast Cancer Patients: Three-Year Follow up a Clinical Trial
    Amlashi, Zahra Keshtpour
    Sheida, Fatemeh
    Anbiaee, Robab
    Tapak, Leili
    Hosseini, Seyed Rohallah
    Mosaedian, Hossein
    Barati, Nastaran
    INTEGRATIVE CANCER THERAPIES, 2024, 23
  • [34] Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer
    Ana Elisa Lohmann
    Judy-Anne W. Chapman
    Margot J. Burnell
    Mark Norman Levine
    Elena Tsvetkova
    Kathleen I. Pritchard
    Karen A. Gelmon
    Patti O’Brien
    Lei Han
    Hope S. Rugo
    Kathy S. Albain
    Edith A. Perez
    Theodore A. Vandenberg
    Haji I. Chalchal
    Ravinder Pal Singh Sawhney
    Lois E. Shepherd
    Pamela Jean Goodwin
    Breast Cancer Research and Treatment, 2015, 150 : 605 - 611
  • [35] Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer
    Lohmann, Ana Elisa
    Chapman, Judy-Anne W.
    Burnell, Margot J.
    Levine, Mark Norman
    Tsvetkova, Elena
    Pritchard, Kathleen I.
    Gelmon, Karen A.
    O'Brien, Patti
    Han, Lei
    Rugo, Hope S.
    Albain, Kathy S.
    Perez, Edith A.
    Vandenberg, Theodore A.
    Chalchal, Haji I.
    Sawhney, Ravinder Pal Singh
    Shepherd, Lois E.
    Goodwin, Pamela Jean
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (03) : 605 - 611
  • [36] Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial
    de Haes, JCJM
    Curran, D
    Aaronson, NK
    Fentiman, IS
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (07) : 945 - 951
  • [37] The protective effect of nano curcumin supplementation on doxorubicin induced cardiotoxicity in breast cancer patients; a randomized, double-blind clinical trial
    Tohidi, Mehdi
    Allahyari, Abolghasem
    Azimi, Sajjad Ataei
    Alimi, Hedieh
    Elyasi, Sepideh
    Seraj, Farid Qoorchi Moheb
    Mehrad-Majd, Hasan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [38] A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
    Lee, Keun Seok
    Ro, Jungsil
    Nam, Byung-Ho
    Lee, Eun Sook
    Kwon, Youngmee
    Kwon, Hye Soo
    Chung, Ki Wook
    Kang, Han Sung
    Kim, Eun A.
    Kim, Seok Won
    Shin, Kyung Hwan
    Kim, Seok-Ki
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 481 - 489
  • [39] Impact of a Music Intervention on Quality of Life in Breast Cancer Patients Undergoing Chemotherapy: A Randomized Clinical Trial
    Lima, Talita Uchoa
    Moura, Ed Carlos Rey
    de Oliveira, Caio Marcio Barros
    Leal, Rachel Jorge Dino Cossetti
    Nogueira Neto, Joao
    Pereira, Emanuel Cabral
    Nascimento, Raniere Victor Braga
    de Oliveira, Eduardo Jose Silva Gomes
    Leal, Plinio da Cunha
    INTEGRATIVE CANCER THERAPIES, 2020, 19
  • [40] A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
    Keun Seok Lee
    Jungsil Ro
    Byung-Ho Nam
    Eun Sook Lee
    Youngmee Kwon
    Hye Soo Kwon
    Ki Wook Chung
    Han Sung Kang
    Eun A Kim
    Seok Won Kim
    Kyung Hwan Shin
    Seok-Ki Kim
    Breast Cancer Research and Treatment, 2008, 109 : 481 - 489
12345